Citation: Abulimiti Moming, Yuan Bai, Qiong Zhu, Jiayin Jin, Yaohui Fang, Shouwei Huang, Qiaoli Wu, Zhengyuan Su, Guoyu Zhao, Shuang Tang, Manli Wang, Zhihong Hu, Yujiang Zhang, Fei Deng, Shu Shen. Genetic heterogeneity and pathogenic potential of historical Crimean-Congo hemorrhagic fever virus isolates in China .VIROLOGICA SINICA, 2026, 41(4) : 832-841.  http://dx.doi.org/10.1016/j.virs.2026.07.012

Genetic heterogeneity and pathogenic potential of historical Crimean-Congo hemorrhagic fever virus isolates in China

  • The Crimean-Congo hemorrhagic fever virus (CCHFV) poses a significant public health threat. In China, CCHFV has been circulating for decades, yet the genomic diversity and pathogenic potential of the circulating strains remain poorly characterized, hindering risk assessment and countermeasure development. In this study, we recovered 24 historical CCHFV strains isolated between 1966 and 2004 from humans, ticks and jerboas in Xinjiang Uyghur Autonomous Region of China. Whole-genome sequencing was performed, followed by comprehensive analyses of their phylogenetic relationships, in vitro infectivity and in vivo pathogenicity. Phylogenetic analyses revealed high genetic heterogeneity, identifying seven genotypes for the L segment, nine for the M segment (including a novel Asia 4 genotype), and nine for the S segment. Amino acid mutation analysis revealed that the mucin-like domain (MLD) of the glycoprotein (GP) exhibited the highest mutation rate, contributing substantially to sequence diversity. In vitro, Asia 2 (75024) and Asia 3 (79121M18) strains exhibited robust replication in monkey-, hamster-, and human-derived cell lines. In C57BL/6 mice, all four representative strains induced viral replication and specific antibody responses (IgM and IgG), causing mild to moderate pathological damage in the liver, spleen, and kidneys. In IFNAR-/- mice, virulence varied markedly among representative strains: Asia 2 and Asia 3 strains were highly lethal (LD50 < 1 TCID50), Asia 1 was moderately virulent (LD50 = 142.5 TCID50), and Asia 4 exhibited atypical, non-dose-dependent mortality. Collectively, our work reports a novel Asia 4 genotype and suggests strain- and lineage-associated differences in virulence for CCHFV in China, providing critical insights for surveillance and targeted countermeasure development.

  • 加载中
  • 10.1016j.virs.2026.07.012-ESM.docx
    1. Aligholipour, F.T., Foldes, K., Hanifehnezhad, A., Yener, I.B., Bilge, D.S., Amirzadeh, K.N., Ergunay, K., Alkan, F., Karaoglu, T., Bodur, H., Ozkul, A., 2019. Bovine herpesvirus type 4 (bohv-4) vector delivering nucleocapsid protein of Crimean-Congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFNα/β/γr-/- mice models. Viruses 11, 237.

    2. Bente, D.A., Alimonti, J.B., Shieh, W.J., Camus, G., Stroher, U., Zaki, S., Jones, S.M., 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089-11100.

    3. Bereczky, S., Lindegren, G., Karlberg, H., Akerstrom, S., Klingstrom, J., Mirazimi, A., 2010. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 91, 1473-1477.

    4. Bhowmick, S., Kasi, K.K., Gethmann, J., Fischer, S., Conraths, F.J., Sokolov, I.M., Lentz, H. H.K., 2022. Ticks on the run: a mathematical model of Crimean-Congo haemorrhagic fever (CCHF)-key factors for transmission. Epidemiologia (Basel) 3, 116-134.

    5. Canakoglu, N., Berber, E., Tonbak, S., Ertek, M., Sozdutmaz, I., Aktas, M., Kalkan, A., Ozdarendeli, A., 2015. Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine. Plos Neglect. Trop. Dis. 9, e3579.

    6. D'Addiego, J., Shah, S., Pektas, A.N., Bagci, B.N.K., Oz, M., Sebastianelli, S., Elaldi, N., Allen, D. J., Hewson, R., 2024. Development of targeted whole genome sequencing approaches for Crimean-Congo haemorrhagic fever virus (CCHFV). Virus Res. 350, 199464.

    7. Dai, S., Wu, Q., Wu, X., Peng, C., Liu, J., Tang, S., Zhang, T., Deng, F., Shen, S., 2021. Differential cell line susceptibility to Crimean-Congo hemorrhagic fever virus. Front. Cell. Infect. Microbiol. 11, 648077.

    8. Fereidouni, M., Apanaskevich, D.A., Pecor, D.B., Pshenichnaya, N.Y., Abuova, G.N., Tishkova, F.H., Bumburidi, Y., Zeng, X., Kuhn, J.H., Keshtkar-Jahromi, M., 2023. Crimean-Congo hemorrhagic fever virus in Central, Eastern, and South-eastern Asia. Virol Sin. 38, 171-183.

    9. Fereidouni, M., Kuhn, J.H., Pecor, D.B., Apanaskevich, D.A., Sherifi, K., Protic, J., Karevska, T., Boshevska, G., Sanchez-Seco, M.P., Papa, A., Keshtkar-Jahromi, M., 2025. Crimean-Congo hemorrhagic fever: An emerging threat in Europe. Virol Sin. 15, S1995-820X(25)00173-7.

    10. Frank, M.G., Weaver, G., Raabe, V., 2024. Crimean-Congo hemorrhagic fever virus for clinicians-epidemiology, clinical manifestations, and prevention. Emerg. Infect. Dis. 30, 854-863.

    11. Freitas, N., Legros, V., Cosset, F., 2022. Crimean-Congo hemorrhagic fever: a growing threat to Europe. C. R. Biol. 345, 17-36.

    12. Guo, R., Shen, S., Zhang, Y., Shi, J., Su, Z., Liu, D., Liu, J., Yang, J., Wang, Q., Hu, Z., Zhang, Y., Deng, F., 2017. A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China. Virol. Sin. 32, 80-88.

    13. Hawman, D.W., Meade-White, K., Leventhal, S., Feldmann, F., Okumura, A., Smith, B., Scott, D., Feldmann, H., 2021. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus. Elife 10, e63906.

    14. Iglesias-Rivas P, Gonzalez-Vazquez LD, Arenas M., 2025. Molecular Evolution and Phylogeography of the Crimean-Congo Hemorrhagic Fever Virus. Viruses. 17, 1054.

    15. Kaushal, N., Baranwal, M., 2023. Mutational analysis of catalytic site domain of CCHFV L RNA segment. J. Mol. Model. 29, 88.

    16. Kaushal, N., Jain, S., Davray, D., Rizvanov, A., Chiang, M., Ohlopkova, O., Khaiboullina, S., Chen, Z., Baranwal, M., 2025. Epidemiology of the Crimean-Congo hemorrhagic fever virus. Acta Trop. 272, 107917.

    17. Kumar, S., Stecher, G., Li, M., Knyaz, C., Tamura, K., 2018. Mega X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547-1549.

    18. Mcfadden, E., Monticelli, S.R., Wang, A., Ramamohan, A.R., Batchelor, T.G., Kuehne, A.I., Bakken, R. R., Tse, A. L., Chandran, K., Herbert, A. S., McLellan, J. S., 2024. Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex. bioRxiv. 188, 303-315.

    19. Moming, A., Yue, X., Shen, S., Chang, C., Wang, C., Luo, T., Zhang, Y., Guo, R., Hu, Z., Zhang, Y., Deng, F., Sun, S., 2018. Prevalence and phylogenetic analysis of Crimean-Congo hemorrhagic fever virus in ticks from different ecosystems in Xinjiang, China. Virol. Sin. 33, 67-73.

    20. Ozdarendeli, A., 2023. Crimean-Congo hemorrhagic fever virus: progress in vaccine development. Diagnostics 13, 2708.

    21. Rao, J., Yao, Y., Hu, X., Jiang, T., Zhang, Z., Gao, G., Liu, H., Peng, Y., Chen, M., Liu, J., Wang, X., Wang, M., Deng, F., Hu, Z., Yuan, Z., Shan, C., 2026. Divergent pathogenesis of two Chinese Crimean-Congo hemorrhagic fever viruses in cynomolgus macaques. J. Infect. Dis. jiag189.

    22. Tang, S., Hu, S., Xiao, J., Zhang, Y., Su, Z., Wu, Q., Yang, J., Liu, X., Zhang. Z., Zhu. Q., Shi. J., Moming. A., Deng, Y., Fan, Z., Guo, R., Sun, S., Zhang, Y., Shen, S., Deng, F., 2023. Monitoring the process and characterizing symptoms of suckling mouse inoculation promote isolating viruses from ticks. Zoonoses 3, 965.

    23. Teng, A. Y., Che, T. L., Zhang, A. R., Zhang, Y. Y., Xu, Q., Wang, T., Sun, Y. Q., Jiang, B. G., Lv, C. L., Chen, J. J., Wang, L. P., Hay, S. I., Liu, W., Fang, L. Q., 2022. Mapping the viruses belonging to the order bunyavirales in China. Infect. Dis. Poverty. 11, 81.

    24. Zhang, Y., Shen, S., Fang, Y., Liu, J., Su, Z., Liang, J., Zhang, Z., Wu, Q., Wang, C., Abudurexiti, A., Hu, Z., Zhang, Y., Deng, F., 2018. Isolation, characterization, and phylogenetic analysis of two new Crimean-Congo hemorrhagic fever virus strains from the Northern region of Xinjiang province, China. Virol. Sin. 33, 74-86.

    25. Zhou, Z., Deng, F., Han, N., Wang, H., Sun, S., Zhang, Y., Hu, Z., Rayner, S., 2013. Reassortment and migration analysis of Crimean-Congo haemorrhagic fever virus. J. Gen. Virol. 94, 2536-2548.

    26. Zivcec, M., Safronetz, D., Scott, D., Robertson, S., Ebihara, H., Feldmann, H., 2013. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J. Infect. Dis. 207, 1909-1921.

  • 加载中

Figures(1)

Article Metrics

Article views(11) PDF downloads(0) Cited by()

Related
Proportional views

    Genetic heterogeneity and pathogenic potential of historical Crimean-Congo hemorrhagic fever virus isolates in China

      Corresponding author: Yujiang Zhang, xjsyzhang@163.com
      Corresponding author: Fei Deng, df@wh.iov.cn
      Corresponding author: Shu Shen, shenshu@wh.iov.cn
    • a. State Key Laboratory of Virology and Biosafety, National Virus Resource Centre, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China;
    • b. Center for Disease Control and Prevention of Xinjiang Uyghur Autonomous Region, Urumqi 830002, China;
    • c. Xinjiang Key Laboratory of Vector-borne Infectious Diseases, Urumqi 830002, China

    Abstract: The Crimean-Congo hemorrhagic fever virus (CCHFV) poses a significant public health threat. In China, CCHFV has been circulating for decades, yet the genomic diversity and pathogenic potential of the circulating strains remain poorly characterized, hindering risk assessment and countermeasure development. In this study, we recovered 24 historical CCHFV strains isolated between 1966 and 2004 from humans, ticks and jerboas in Xinjiang Uyghur Autonomous Region of China. Whole-genome sequencing was performed, followed by comprehensive analyses of their phylogenetic relationships, in vitro infectivity and in vivo pathogenicity. Phylogenetic analyses revealed high genetic heterogeneity, identifying seven genotypes for the L segment, nine for the M segment (including a novel Asia 4 genotype), and nine for the S segment. Amino acid mutation analysis revealed that the mucin-like domain (MLD) of the glycoprotein (GP) exhibited the highest mutation rate, contributing substantially to sequence diversity. In vitro, Asia 2 (75024) and Asia 3 (79121M18) strains exhibited robust replication in monkey-, hamster-, and human-derived cell lines. In C57BL/6 mice, all four representative strains induced viral replication and specific antibody responses (IgM and IgG), causing mild to moderate pathological damage in the liver, spleen, and kidneys. In IFNAR-/- mice, virulence varied markedly among representative strains: Asia 2 and Asia 3 strains were highly lethal (LD50 < 1 TCID50), Asia 1 was moderately virulent (LD50 = 142.5 TCID50), and Asia 4 exhibited atypical, non-dose-dependent mortality. Collectively, our work reports a novel Asia 4 genotype and suggests strain- and lineage-associated differences in virulence for CCHFV in China, providing critical insights for surveillance and targeted countermeasure development.

    Figure (1)  Reference (26) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return